Iron and 8-Isoprostane Levels in Acute and Chronic Wounds

Journal of Investigative Dermatology

Volumn 121, Issue 4, 2003, Pages 918-925

  Yeoh Ellerton, Sim ^a   Stacey, Michael C ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Iron protein; Lipid peroxidation; Wounds

Indexed keywords

8 ISOPROSTANE; ANTIOXIDANT; FERRITIN; IRON; ISOPROSTANE; TRANSFERRIN; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BODY FLUID; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; LEG ULCER; MALE; MASTECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BIOPSY; STAINING; TISSUE INJURY; WOUND; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 0141921992     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12471.x     Document Type: Article

References (55)

1. Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A: Overload of iron in the skin of patients with varicose ulcers. Arch Dermatol 124:1376-1378, 1988
2. Angel MF, Ramasastry SS, Swartz WM, Basford RE, Futrell JW: The causes of skin ulcerations associated with venous insufficiency: A unifying hypothesis. Plastic Reconstructive Surg 79:289-297, 1987
3. Aust SD: Ferritin as a source of iron and protection from iron-induced toxicities. Toxicol Lett 82/83:941-944, 1995
4. Awad JA, Morrow JD: Excretion of F2-isoprostanes in bile: A novel index of hepatic lipid peroxidation. Hepatology 22:962-968, 1995
5. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM: Endothelial-cell heme uptake from heme proteins. Induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci, USA 90:9285-9289, 1993
6. Castell JV, Gomez-Lechon MJ, David M, et al: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237-239, 1989
7. Cheatle TR, Sarin S, Coleridge Smith PD, Scurr JH: The pathogenesis of skin damage in venous disease: A review. Euro J Vasc Surg 5:115-123, 1991
8. Connelly KG, Moss M, Parsons PE, et al: Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respiratory Crit Care Med 155:21-25, 1997
9. Cross CE, Halliwell B, Borish ET, et al: Oxygen radicals and human disease [clinical conference]. Ann Intern Med 107:526-545, 1987
10. Dacie JV, Lewis SM: Practical Haematology, 6th edn. Churchill Livingstone, London, UK: 1984; p 108-109
11. Dormandy JA: Pathophysiology of venous leg ulceration - An update. Angiology J Vascular 48:71-75, 1997
12. Edwards AT, Herrick SE, Suarez-Mendez VJ, McCollum CN: Oxidants, antioxidants and venous ulceration. Br J Surg 79:443, 1992
13. Fontecave M, Pierre JL: Iron: Metabolism, toxicity and therapy. Biochimie 75:767-773, 1993
14. Gardner MJ, Altman DG: Statistics with confidence. Universities Press, Belfast: 1989; p 72-74
15. Gutteridge JMC: Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochim Biophys Acta 869:119-127, 1986
16. Halliwell B, Gutteridge JMC: The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 8:89-193, 1985
17. Harford JB, Klausner RD: Coordinate post-transcriptional regulation of ferritin and transferrin receptor expression: The role of regulated RNA-protein interaction. Enzyme 44:28-41, 1990
18. Herrick SE, Sloan P, McGurk M, Freak L, McCollume CN, Ferguson MW: Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 141:1085-1095, 1992
19. Hirayama M, Kohgo Y, Kondo H, et al: Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron. Hepatology 18:874-880, 1993
20. James TJ, Hughes MA, Hofman D, Cherry GW, Taylor RP: Antioxidant characteristics of chronic wound fluid. Br J Dermatol 145:185-186, 2001
21. Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y: Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 19:1468-1475, 1994
22. Konijn AM: Iron metabolism in inflammation. Bailliere's Clin Haematol 7:829-849, 1994
23. Konijn AM, Carmel N, Levy R, Hershko C: Ferritin synthesis in inflammation II. Mechanism of increased ferritin synthesis. Br J Haematol 49:361-370, 1981
24. Lesnefsky EJ: Tissue iron overload and mechanisms of iron-catalysed oxidative injury. In: Armstrong D (ed). Free Radicals in Diagnostic Medicine. Kluwer Academic, New York: 1994; p 129-146
25. Ludbrook J: Comparing methods of measurements. Clin Exp Pharmacol Physiol 24:193-203, 1997
26. MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E: Measures of total free radical activity in critically ill patients. Clin Biochem 32:263-268, 1999
27. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 312:159-163, 1985
28. McCord JM: Effects of positive iron status at a cellular level. Nut Rev 54:85-88, 1996
29. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM: Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci USA 88:4946-4950, 1991
30. Minuz P, Andrioli G, Degan M, et al: The F2-isoprostane 8-epiprostaglandin F2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Throm Vasc Biol 18:1248-1256, 1998
31. Morrow JD, Jackson Roberts LJ 2nd: Mass spectrometry of prostanoids F2-isoprostanes produced by non-cyclooxygenase free radical-catalysed mechanisms. Meth Enzymol 233:163-174, 1994
32. Morrow JD, Jackson Roberts LJ 2nd: The isoprostanes: Current knowledge and directions for future research. Biochem Pharmacol 51:1-9, 1996
33. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ 2nd: Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci, USA 89:10721-10725, 1992
34. Myers HL: Topical chelation therapy for varicose pigmentation. American College of Angiology 11th Annual Meeting, New York: 1965; p 66-68
35. Okada S: Iron-induced tissue damage and cancer: The role of reactive oxygen species-free radicals. Pathol Int 46:311-332, 1996
36. Ponka P: Cell biology of heme. Am J Med Sci 318:241-256, 1999
37. Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB: Measurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation - A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 272:209-215, 1999
38. Reif DW: Ferritin as a source of iron for oxidative damage. Free Rad Biol Med 12: 417-427, 1992
39. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN: Translational control during the acute phase response: Ferritin synthesis in response to interleukin-1. J Biol Chem 265:14572-14578, 1990
40. Ryan TP, Aust SD: The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol 22:119-141, 1992
41. Saddi R, Fagard R, Feingold J, Sabatier MM: Iron stimulation of ferritin biosynthesis I. Localization of the iron effect. Biochimie 56:741-749, 1974
42. Salim AS: The role of oxygen-derived free radicals in the management of venous (varicose) ulceration: A new approach. World J Surg 15:264-269, 1991
43. Shukla A, Rasik AM, Patnaik GK: Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound. Free Rad Res 26:93-101, 1997
44. Thomas CE, Morehouse LA, Aust SD: Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem 260:3275-3280, 1985
45. Trenam CW, Blake DR, Morris CJ: Skin inflammation: Reactive oxygen species and the role of iron. J Invest Dermatol 99:675-682, 1992
46. Trengove N, Beilefeldt-Ohmann H, Stacey M: Cytokine profile of wound fluid from chronic leg ulcers. Wound Repair Regeneration 2:228, 1994
47. Trengove N, Stacey MC, MacAuley S, et al: Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regeneration 7:442-452, 1999
48. Trevor A, Mori TA, Croft KD, Puddey IB, Beilin LJ: An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography mass spectrometry. Anal Biochem 268:117-125, 1999
49. Walters GO, Miller FM, Worwood M: Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 26:770-772, 1973
50. Ward RJ, O'Connell MJ, Dickson DP, et al: Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis. Biochem Biophys Acta 993:131-133, 1989
51. Wenk J, Foitzik A, Achterberg V, et al: Selective pick-up of increased iron by deferoxamine-couplcd cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: A new dressing concept. J Invest Dermatol 116:833-839, 2001
52. Whiston RJ, Hallett MB, Davies EV, Harding KG, Lane IF: Inappropriate neutrophil activation in venous disease. Br J Surg 81:695-698, 1994
53. Winterbourn CC: Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol Lett 82/83:969-974, 1995
54. Yee HY, Goodwin FJ: Simultaneous determination of copper and iron in a single aliquot of serum. Clin Chem 20:188-191, 1974
55. Zuyderhoudt FM, Sindram JW, Marx JJ, Jorning GG, van Gool J: The amount of ferritin and hemosiderin in the livers of patients with iron loading diseases. Hepatology 3:232-235, 1983